Document:

BioElectronics Corporation - Exhibit 4.2 - Prepared By TNT Filings Inc.

 

Exhibit 4.2 

NEITHER THIS WARRANT NOR THE SECURITIES
UNDERLYING THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, AND NEITHER THIS WARRANT NOR
THE SECURITIES UNDERLYING THIS WARRANT MAY BE OFFERED FOR SALE, SOLD OR
OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR IN ACCORDANCE WITH AN
EXEMPTION FROM REGISTRATION UNDER THAT ACT AND APPLICABLE STATE SECURITIES LAWS.
TRANSFER OF THIS WARRANT IS RESTRICTED UNDER PARAGRAPH 2 BELOW. 

PLACEMENT AGENT'S WARRANT TO PURCHASE COMMON
STOCK 

BIOELECTRONICS CORPORATION 

(a Maryland corporation) 

Dated: April 4, 2005 

PAW-7 

THIS IS TO CERTIFY THAT, 
for value received, Matthew Taylor ("Taylor") and his successors
and permitted assigns (with Taylor, either together or individually, a "Warrant
Holder"), are entitled, subject to the terms and conditions set forth in this
common stock purchase warrant (this "Warrant"), to purchase from BioElectronics
Corporation, a Maryland corporation (the "Company"), at any time and from time
to time after 9:00 A.M., New York time, on the Initial Exercise Date (as defined
in Section 1 below) and on or prior to 5:00 P.M., New York time, on the
Expiration Date (as defined in Section 1 below) up to 10,000 shares of the
common stock, par value $0.001 per share, of the Company (the "Common Stock") at
an exercise price of $0.40 per share of Common Stock the ("Exercise Price").

This Warrant is issued pursuant to a Placement
Agent Agreement, dated as of December 1, 2004, between the Company and Buckman,
Buckman & Reid, Inc. ("BB&R") in connection with a private offering through BB&R
(the "Private Offering") of up to 10,000,000 Units (the "Investor Units").

1 

1. Exercise of the Placement Agent's Warrant. 

  (a) The rights represented by this Warrant shall be
  exercised at the prices and during the periods as follows: 

  
    (i) Initial Exercise Date: Beginning at
    9:00 A.M., New York time, on the date hereof and until the Expiration Date,
    inclusive, the Warrant Holder shall have the option to purchase Common Stock
    hereunder at the Exercise Price, subject to adjustment as provided in
    paragraph 7 hereof. 

    (ii) Expiration Date: This Warrant shall
    expire effective at 5:00 p.m., New York time, on April 4, 2007 after which
    time the Warrant Holder shall have no right to purchase any Common Stock
    hereunder. 

  

  (b) The rights represented by this Warrant
  may be exercised at any time within the period above specified, in whole or in
  part, by (i) the surrender of this Warrant (with the purchase form at the end
  hereof properly executed) at the principal executive office of the Company (or
  such other office or agency of the Company as it may designate by notice in
  writing to the Warrant Holder at the address of the Warrant Holder appearing
  on the books of the Company); (ii) payment to the Company by certified check
  (or other form of payment acceptable to the Company) of the respective
  Exercise Price then in effect for the number of shares of Common Stock
  specified in the above-mentioned purchase form together with applicable stock
  transfer taxes, if any; and (iii) delivery to the Company of a duly executed
  agreement signed by the person(s) designated in the purchase form to the
  effect that such person(s) agree(s) to be bound by the provisions of paragraph
  5 and of paragraph 6 hereof. This Warrant shall be deemed to have been
  exercised, in whole or in part to the extent specified, immediately prior to
  the close of business on the date this Warrant is surrendered and payment is
  made in accordance with the foregoing provisions of this paragraph 1, and the
  person or persons in whose name or names the certificates for the shares of
  Common Stock shall be issuable upon such exercise shall become the Warrant
  Holder or Warrant Holders of record of such shares of Common Stock at that
  time and date. Certificates representing the shares of Common Stock so
  purchased shall be delivered to the Warrant Holder within a reasonable time,
  not exceeding ten (10) business days, after the rights represented by this
  Warrant shall have been so exercised. 

2. Restrictions on Transfer. 

This Warrant shall not be transferred, sold,
pledged, assigned or hypothecated unless such assignment shall be effected by
the Warrant Holder by (i) completing and executing the form of assignment at the
end hereof and (ii) surrendering this Warrant with such duly completed and
executed assignment form for cancellation at the office or agency of the Company
referred to in 

2 

Paragraph 9 hereof; whereupon the Company shall issue, in the
name or names specified by the Warrant Holder (including the Warrant Holder) a
new Warrant or Warrants of like tenor and representing in the aggregate rights
to purchase the same number of shares of Common Stock as are then purchasable
hereunder. Notwithstanding the foregoing, the Company may require prior to
registering any transfer of this Warrant an opinion of counsel reasonably
satisfactory to the Company that such transfer complies with the provisions of
the Securities Act of 1933, as amended (the "Act"), and the rules and
regulations thereunder. 

3. Covenants of the Company 

  (a) The Company covenants and agrees that all Common Stock
  issuable upon exercise of this Warrant will, upon issuance, be duly and
  validly issued, fully paid and non-assessable and no personal liability will
  attach to the holder thereof by reason of being such a holder, other than as
  set forth herein. 

  (b) The Company covenants and agrees that during the period
  within which this Warrant may be exercised, the Company will at all times have
  authorized and reserved a sufficient number of shares of Common Stock issuable
  upon the exercise of this Warrant 

4. No Rights of Stockholder. 

This Warrant shall not entitle the Warrant Holder to any
voting rights or other rights as a stockholder of the Company, either at law or
in equity, and the rights of the Warrant Holder are limited to those expressed
in this Warrant and are not enforceable against the Company except to the extent
set forth herein. 

5. Registration Rights. 

The Warrant Holder will be entitled to exercise registration
rights with respect to the Common Stock issuable upon exercise of this Warrant,
which rights will be identical to the registration rights granted to investors
in the Units pursuant to the terms of the Registration Rights Agreement executed
by the Company and the investors in the Units (the "Registration Rights
Agreement"), specifically as follows: 

  (a) Registration on Form SB-2: The Company will file, within
  180 days of the date on which the final subscription agreement relating to the
  sale of Units is accepted by the Company and the transactions thereby are
  consummated (the "Final Closing Date"), a registration statement on Form SB-2
  (or such other form as is appropriate) registering the offer and sale of
  registrable securities, as that term is defined in the Registration Rights
  Agreement (the "Registrable Securities"), by the holders thereof. The Company
  shall keep such registration statement effective until the first anniversary
  of the Final Closing Date. 

  (b) Piggy-Back Registration: If at any time following the
  first anniversary of the Final Closing Date there is not an effective
  registration statement covering all of the Registrable 

3

Securities issuable upon exercise of the
Warrants and the Company shall determine to prepare and file with the Commission
a registration statement under the Act relating to an offering for its own
account or the account of others of any of its equity securities, other than on
Form S-4 or Form S-8 (each as promulgated under the Act) or their then
equivalents relating to equity securities to be issued solely in connection with
any acquisition of any entity or business or equity securities issuable in
connection with stock option or other employee benefit plans, respectively, then
the Company shall send to each Warrant Holder written notice of such
determination and, if within fifteen (15) days after receipt of such notice, any
such Warrant Holders shall so request in writing, the Company shall include in
such registration statement all or any part of such Registrable Securities
issuable upon exercise of the Warrants that such Warrant Holder requests to be
registered to the extent the Company may do so without violating registration
rights of others which exist as of the date of the Registration Rights
Agreement, subject to customary underwriter cutbacks applicable to all holders
of registration rights. 

6. Indemnification. 

  (a) Whenever pursuant to Paragraph 5, a registration
  statement relating to any Common Stock issuable upon exercise of this Warrant
  is filed under the Act, or is amended or supplemented, the Company will
  indemnify and hold harmless the Warrant Holder (such Warrant Holder
  hereinafter referred to as the "Distributing Warrant Holder"), each person, if
  any, who controls (within the meaning of the Act) the Distributing Warrant
  Holder, and each officer, employee, partner or agent of the Distributing
  Warrant Holder, if the Distributing Warrant Holder is a broker or dealer,
  against any losses, claims, damages or liabilities, joint or several, to which
  the Distributing Warrant Holder may become subject under the Act or otherwise,
  insofar as such losses, claims, damages or liabilities (or actions in respect
  thereof) arise out of or are based upon any untrue statement or alleged untrue
  statement of any material fact contained in any such registration statement or
  any preliminary prospectus or final prospectus constituting a part thereof or
  any amendment or supplement thereto, or arise out of or are based upon the
  omission to state therein a material fact required to be stated therein or
  necessary to make the statements therein not misleading; and will reimburse
  the Distributing Warrant Holder for any legal or other expenses reasonably
  incurred by the Distributing Warrant Holder, in connection with investigating
  or defending any such loss, claim, damage, liability or action; provided,
  however, that the Company will not be liable in any such case (i) to the
  extent that any such loss, claim, damage or liability arises out of or is
  based upon an untrue statement or alleged untrue statement or omission or
  alleged omission made in said registration statement, said preliminary
  prospectus, said final prospectus or said amendment or supplement in reliance
  upon and in conformity with written information furnished by such Distributing
  Warrant Holder, each person, if any, who controls (within the meaning of the
  Act) the Distributing Warrant Holder, and each officer, employee, partner or
  agent of the Distributing Warrant Holder, any other Distributing Warrant
  Holder or any such underwriter for use in the preparation thereof, and (ii)
  such losses, claims, damages or liabilities arise out of or are based upon any
  actual or alleged untrue statement or omission made in or from any preliminary
  prospectus, but corrected in the final prospectus, as amended or supplemented.
  

4 

  (b) Whenever pursuant to Paragraph 5 a
  registration statement relating to the Common Stock issuable upon the exercise
  of this Warrant is filed under the Act, or is amended or supplemented, the
  Distributing Warrant Holder will indemnify and hold harmless the Company, each
  of its directors, each of its officers who have signed said registration
  statement or such amendments and supplements thereto, and each person, if any,
  who controls the Company (within the meaning of the Act) and each officer,
  employee, partner or agent of the Company against any losses, claims, damages
  or liabilities to which the Company or any such director, officer, controlling
  person, employee, partner or agent may become subject under the Act or
  otherwise, insofar as such losses, claims, damages or liabilities (or actions
  in respect thereof) arise out of or are based upon any untrue or alleged
  untrue statement of any material fact contained in any such registration
  statement or any preliminary prospectus or final prospectus constituting a
  part thereof, or any amendment or supplement thereto, or arise out of or are
  based upon the omission or the alleged omission to state therein a material
  fact required to be stated therein or necessary to make the statements therein
  not misleading, in each case to the extent, but only to the extent, that such
  untrue statement or alleged untrue statement or omission was made in said
  registration statement, said preliminary prospectus, said final prospectus or
  said amendment or supplement in reliance upon and in conformity with written
  information furnished by such Distributing Warrant Holder for use in the
  preparation thereof; and will reimburse the Company or any such director,
  officer, controlling person, employee, partner or agent for any legal or other
  expenses reasonably incurred by them in connection with investigating or
  defending any such loss, claim, damage, liability or action. 

  (c) Promptly after receipt by an indemnified
  party under this Paragraph 6 of notice of the commencement of any action, such
  indemnified party will, if a claim in respect thereof is to be made against
  any indemnifying party, give the indemnifying party notice of the commencement
  thereof; but the omission to so notify the indemnifying party will not relieve
  it from any liability which it may have to any indemnified party otherwise
  than under this Paragraph 6. 

  (d) In case any such action is brought
  against any indemnified party, and it notifies an indemnifying party of the
  commencement thereof, the indemnifying party will be entitled to participate
  in, and, to the extent that it may wish, jointly with any other indemnifying
  party similarly notified, to assume the defense thereof with counsel
  reasonably satisfactory to such indemnified party, and after notice from the
  indemnifying party to such indemnified party of its election to so assume the
  defense thereof, the indemnifying party will not be liable to such indemnified
  party under this Paragraph 6 for any legal or other expenses subsequently
  incurred by such indemnified party in connection with the defense thereof
  other than reasonable costs of investigation. 

  (e) If an indemnifying party assumes the
  defense of a claim pursuant to Section 6(d), any settlement or compromise of
  such claim shall be effected only with the consent of the indemnified party,
  which consent shall not be unreasonably withheld. 

7. Adjustments of Purchase Price and Number of Shares. 

5 

  (a) Subdivision and Combination: In
  case the Company shall at any time subdivide or combine the outstanding shares
  of Common Stock by way of stock split, reverse stock split or the like, the
  Exercise Price shall promptly be proportionately increased or decreased.
  

  (b) Adjustment in Number of Shares: Upon
  each adjustment of the Exercise Price pursuant to the provisions of this
  Section 7, the number of shares of Common Stock issuable upon the exercise of
  this Warrant shall be adjusted to a number of shares of Common Stock that is
  determined by multiplying a number equal to the Exercise Price in effect
  immediately prior to such adjustment by the number of shares of Common Stock
  issuable upon exercise of this Warrant immediately prior to such adjustment
  and dividing the product so obtained by the adjusted Exercise Price. 
  

  (c) Reclassification, Consolidation, Merger,
  etc.: In case of any reclassification or change of the outstanding
  shares of Common Stock (other than a change in par value to no par value, or
  from no par value to par value, or as a result of a subdivision or
  combination), or in the case of any consolidation of the Company with, or
  merger of the Company into, another corporation (other than a consolidation or
  merger in which the Company is the surviving corporation and which does not
  result in any reclassification or change of the outstanding shares of Common
  Stock, except a change as a result of a subdivision or combination of such
  shares or a change in par value, as aforesaid), or in the case of a sale or
  conveyance to another corporation of all or a substantial part of the property
  of the Company, the Warrant Holder shall thereafter have the right to purchase
  the kind and number of shares of stock and other securities and property
  receivable upon such reclassification, change, consolidation, merger, sale or
  conveyance as if the Warrant Holder were the owner of the shares of Common
  Stock immediately prior to any such events at a price equal to the product of
  (x) the number of shares of Common Stock issuable upon exercise of this
  Warrant and (y) the Exercise Price in effect immediately prior to the record
  date for such reclassification, change, consolidation, merger, sale or
  conveyance as if such Warrant Holder had exercised this Warrant. 

  (d) Dividends and Other Distributions with Respect to
  Outstanding Securities: In the event that the Company shall at any time
  prior to the exercise of this Warrant declare a dividend (other than a
  dividend consisting solely of shares of Common Stock or a cash dividend or
  distribution payable out of current or retained earnings) or otherwise
  distribute to its shareholders any monies, assets, property, rights, evidences
  of indebtedness, securities (other than shares of Common Stock), whether
  issued by the Company or by another person or entity, or any other thing of
  value, the Warrant Holder of the unexercised Warrant shall thereafter be
  entitled, in addition to the shares of Common Stock or other securities
  receivable upon the exercise thereof, to receive, upon the exercise of this
  Warrant, the same monies, property, assets, rights, evidences of indebtedness,
  securities or any other thing of value that the Warrant Holder would have been
  entitled to receive at the time of such dividend or distribution if the
  Warrant Holder had exercised this Warrant immediately prior to such dividend
  or distribution. At the time of any such dividend or distribution, the Company
  shall make appropriate reserves to ensure the timely performance of the
  provisions of this Subsection 7(d). 

6 

  (e) Fractional Shares: Any fraction of a
  share which the Warrant Holder would be entitled to purchase upon exercise of
  this Warrant shall be rounded down to the nearest whole number of shares. The
  Company will pay cash for the value of any fractional shares otherwise
  issuable. The Warrant Holder, by his acceptance hereof, expressly waives any
  right to receive any fractional share of stock upon exercise of this Warrant.
  

  (f) Warrant Certificate After
  Adjustment: Irrespective of any change pursuant to this Section 7 in the
  Exercise Price or in the number, kind or class of shares or other securities
  or other property obtainable upon exercise of this Warrant, this Warrant may
  continue to express as the Exercise Price and as the number of shares of
  Common Stock obtainable upon exercise, the same price and number of shares of
  Common Stock as are stated herein. 

  (g) Statement of Calculation: Whenever the
  Exercise Price shall be adjusted pursuant to the provisions of this Section 7,
  the Company shall forthwith file at its principal office, a statement signed
  by an executive officer of the Company specifying the adjusted Exercise Price
  determined as above provided in such section and a certificate of the
  independent public accountants regularly retained by the Company. Such
  statement shall show in reasonable detail the method of calculation of such
  adjustment and the facts requiring the adjustment and upon which the
  calculation is based. The Company shall forthwith cause a notice setting forth
  the adjusted Exercise Price to be sent by certified mail, return receipt
  requested, postage prepaid, to the Warrant Holder. 

8. Definition of "Common Stock." 

For the purpose of this Warrant, the term
"Common Stock" shall mean, in addition to the class of stock designated as the
Common Stock of the Company on the date hereof, any class of stock resulting
from successive changes or reclassifications of the Common Stock consisting
solely of changes in par value, or from par value to no par value, or from no
par value to par value. If at any time, as a result of an adjustment made
pursuant to one or more of the provisions of Section 7 hereof, the shares of
stock or other securities or property obtainable upon exercise of this Warrant
shall include securities of the Company other than shares of Common Stock or
securities of another corporation, then thereafter the amount of such other
securities so obtainable shall be subject to adjustment from time to time in a
manner and upon terms as nearly equivalent as practicable to the provisions with
respect to Common Stock contained in Section 7 hereof and all other provisions
of this Warrant with respect to Common Stock shall apply on like terms to any
such other shares or other securities. 

9. Miscellaneous. 

  (a) This Warrant shall be governed by and in accordance with
  the laws of the State of New York. 

  (b) All notices, requests, consents and
  other communications hereunder shall be made in writing and shall be deemed to
  have been duly made when delivered, or mailed by registered or certified mail,
  return receipt requested: (i) if to a Warrant Holder, to the address of the
  

7

  Warrant Holder as shown on the books of the Company, or (ii)
  if to the Company, BioElectronics Corporation, 401 Rosemont Avenue, Third
  Floor, Rosenstock Hall, Frederick, Maryland 21701. 

  (c) The Company and BB&R may from time to
  time supplement or amend this Warrant without the approval of the Warrant
  Holders in order to cure any ambiguity, to correct or supplement any provision
  contained herein which may be defective or inconsistent with any provisions
  herein, or to make any other provisions in regard to matters or questions
  arising hereunder which the Company and BB&R may deem necessary or desirable
  and which the Company and BB&R deem not to adversely affect the interest of
  the Warrant Holder, provided all such supplements, amendments and/or other
  provisions shall be in writing. 

  (d) All the covenants and provisions of this
  Warrant by or for the benefit of the Company and the Warrant Holder inure to
  the benefit of their respective successors and assigns hereunder. 

  (e) Nothing in this Warrant shall be
  construed to give to any person or corporation other than the Company and the
  Warrant Holder any legal or equitable right, and any such right is for the
  sole and exclusive benefit of the Company and the Warrant Holder. 

[remainder of page intentionally left blank]

8 

IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officer as of this 4th day of April, 2005. 

  	BIOELECTRONICS
      CORPORATION
	 	 
	 	/s/ Andrew
      Whelan
	 	Name: Andrew
      Whelan
	Title:	President

9

PURCHASE FORM 

(To be signed only upon exercise of the
Warrant) 

The undersigned registered owner of this
Warrant irrevocably exercises this Warrant and agrees to purchase
____________shares of Common Stock of BioElectronics Corporation all at the
price and on the terms and conditions specified in this Warrant. 

Dated: __________________ 

_____________________________________ 

(Signature of Registered Owner) 

_____________________________________ 

Address 

_____________________________________ 

(City) (State) (Zip) 

10 

TRANSFER FORM 

(To be signed only upon transfer of the Warrant) 

For value received, the undersigned hereby
sells, assigns, and transfers unto _____________________________ the right to
purchase Shares of Common Stock of BioElectronics Corporation represented by the
foregoing Warrant to the extent of __________ Shares and appoints
________________, attorney to transfer such rights on the books of
________________, with full power of substitution in the premises. 

Dated: __________________ 

_______________________________

(Name of Warrant Holder) 

_______________________________

Address 

_______________________________

In the presence of: 

_______________________________ 

_______________________________ 

11BioElectronics Corporation: Exhibit 4.3 - Prepared by TNT Filings Inc.

 

Exhibit 4.3

NEITHER THIS WARRANT NOR THE SECURITIES UNDERLYING THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, AND NEITHER THIS WARRANT NOR THE SECURITIES UNDERLYING THIS WARRANT MAY BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR IN ACCORDANCE WITH AN EXEMPTION FROM REGISTRATION UNDER THAT ACT AND APPLICABLE STATE SECURITIES LAWS. TRANSFER OF THIS WARRANT IS RESTRICTED UNDER PARAGRAPH 2 BELOW.

PLACEMENT AGENT'S WARRANT TO PURCHASE COMMON STOCK

BIOELECTRONICS CORPORATION

(a Maryland corporation)

Dated: April 4, 2005

__________

 

THIS IS TO CERTIFY THAT,  for value received, Abdul Jabbar Al Sayegh (“Sayegh”) and his successors and permitted assigns (with Sayegh, either together or individually, a “Warrant Holder”), are entitled, subject to the terms and conditions set forth in this common stock  purchase warrant (this “Warrant”), to purchase from BioElectronics Corporation, a Maryland corporation (the “Company”), at any time and from time to time after 9:00 A.M., New York time, on the Initial Exercise Date (as defined in Section 1 below) and on or prior to 5:00 P.M., New York time, on the Expiration Date (as defined in Section 1 below) up to 41,500 shares of the common stock, par value $0.001 per share, of the Company (the “Common Stock”) at an exercise price of  $0.33 per share of Common Stock the (“Exercise Price”).  

This Warrant is issued pursuant to a Placement Agent Agreement, dated as of December 1, 2004, between the Company and Buckman, Buckman & Reid, Inc. (“BB&R”) in connection with a private offering through BB&R (the “Private Offering”) of up to 10,000,000 Units (the “Investor Units”).

 

1

1.

Exercise of the Placement Agent's Warrant.

(a)

The rights represented by this Warrant shall be exercised at the prices and during the periods as follows:

(i)

Initial Exercise Date: Beginning at 9:00 A.M., New York time, on the date hereof and until the Expiration Date, inclusive, the Warrant Holder shall have the option to purchase  Common Stock hereunder at the Exercise Price, subject to adjustment as provided in paragraph 7 hereof.

(ii)

Expiration Date: This Warrant shall expire effective at 5:00 p.m.,  New York time, on April 4, 2010, after which time the Warrant Holder shall have no right to purchase any Common Stock hereunder.

(b)

The rights represented by this Warrant may be exercised at any time within the period above specified, in whole or in part, by (i) the surrender of this Warrant (with the purchase form at the end hereof properly executed) at the principal executive office of the Company (or such other office or agency of the Company as it may designate by notice in writing to the Warrant Holder at the address of the Warrant Holder appearing on the books of the Company); (ii) payment to the Company by certified check (or other form of payment acceptable to the Company) of the respective Exercise Price then in effect for the number of shares of Common Stock specified in the above-mentioned purchase form together with applicable stock transfer taxes, if any; and (iii) delivery to the Company of a duly executed agreement signed by the person(s) designated in the purchase form to the effect that such person(s) agree(s) to be bound by the provisions of paragraph 5 and of paragraph 6 hereof. This Warrant shall be deemed to have been exercised, in whole or in part to the extent specified, immediately prior to the close of business on the date this Warrant is surrendered and payment is made in accordance with the foregoing provisions of this paragraph 1, and the person or persons in whose name or names the certificates for the shares of Common Stock shall be issuable upon such exercise shall become the Warrant Holder or Warrant Holders of record of such shares of Common Stock at that time and date. Certificates representing the shares of Common Stock so purchased shall be delivered to the Warrant Holder within a reasonable time, not exceeding ten  (10) business days, after the rights represented by this Warrant shall have been so exercised.
 

2.

 

Restrictions on Transfer.

This Warrant shall not be transferred, sold, pledged, assigned or hypothecated unless such assignment shall be effected by the Warrant Holder by (i) completing and executing the form of assignment at the end hereof and (ii) surrendering this Warrant with such duly completed and executed assignment form for cancellation at the office or agency of the Company referred to in Paragraph 9 hereof; whereupon the Company shall issue, in the name or names specified by the Warrant Holder (including the Warrant Holder) a new Warrant or Warrants of like tenor and representing in the aggregate rights to purchase the same number of shares of Common  Stock as are then purchasable hereunder. Notwithstanding the foregoing, the Company may require prior to registering any transfer of this Warrant an opinion of counsel reasonably satisfactory to the Company that such transfer complies with the provisions of the Securities Act of 1933, as amended (the “Act”), and the rules and regulations thereunder.

2

3.

 

 

 

Covenants of the Company

(a)

The Company covenants and agrees that all shares of Common Stock issuable upon exercise of this Warrant will, upon issuance, be duly and validly issued, fully paid and non-assessable and no personal liability will attach to the holder thereof by reason of being such a holder, other than as set forth herein.  

(b)

The Company covenants and agrees that during the period within which this Warrant may be exercised, the Company will at all times have authorized and reserved a sufficient number of shares of Common Stock issuable upon the exercise of this Warrant

4.

 

No Rights of Stockholder.

This Warrant shall not entitle the Warrant Holder to any voting rights or other rights as a stockholder of the Company, either at law or in equity, and the rights of the Warrant Holder are limited to those expressed in this Warrant and are not enforceable against the Company except to the extent set forth herein.

5.

 

Registration Rights.

The Warrant Holder will be entitled to exercise registration rights with respect to the Common Stock issuable upon exercise of this Warrant, which rights will be identical to the registration rights granted to investors in the Units pursuant to the terms of the Registration Rights Agreement executed by the Company and the investors in the Units (the “Registration Rights Agreement”), specifically as follows:

(a)

Registration on Form SB-2:  The Company will file, within 180 days of the date on which the final subscription agreement relating to the sale of Units is accepted by the Company and the transactions thereby are consummated (the “Final Closing Date”), a registration statement on Form SB-2 (or such other form as is appropriate) registering the offer and sale of registrable securities, as that term is defined in the Registration Rights Agreement (the “Registrable Securities”), by the holders thereof.  The Company shall keep such registration statement effective until the first anniversary of the Final Closing Date.

(b)    Piggy-Back Registration:  If at any time following the first anniversary of the Final Closing Date there is not an effective registration statement covering all of the Registrable Securities issuable upon exercise of the Warrants and the Company shall determine to prepare and file with the Commission a registration statement under the Act relating to an offering for its own account or the account of others of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection with stock option or other employee benefit plans, respectively, then the Company shall send to each Warrant Holder written notice of such determination and, if within fifteen (15) days after receipt of such notice, any such Warrant Holders shall so request in writing, the Company shall include in such registration statement all or any part of such Registrable Securities issuable upon exercise of the Warrants that such Warrant Holder requests to be registered to the extent the Company may do so without violating registration rights of others which exist as of the date of the Registration Rights Agreement, subject to customary underwriter cutbacks applicable to all holders of registration rights.

3

6.

 

Indemnification.

(a)

Whenever pursuant to Paragraph 5, a registration statement relating to any Common Stock issuable upon exercise of this Warrant is filed under the Act, or is amended or supplemented, the Company will indemnify and hold harmless the Warrant Holder (such Warrant Holder hereinafter referred to as the "Distributing Warrant Holder"), each person, if any, who controls (within the meaning of the Act) the Distributing Warrant Holder, and each officer, employee, partner or agent of the Distributing Warrant Holder, if the Distributing Warrant Holder is a broker or dealer, against any losses, claims, damages or liabilities, joint or several, to which the Distributing Warrant Holder may become subject under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in any such registration statement or any preliminary prospectus or final prospectus constituting a part thereof or any amendment or supplement thereto, or arise out of or are based upon the omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; and will reimburse the Distributing Warrant Holder for any legal or other expenses reasonably incurred by the Distributing Warrant Holder, in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the Company will not be liable in any such case (i) to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in said registration statement, said preliminary prospectus, said final prospectus or said amendment or supplement in reliance upon and in conformity with written information furnished by such Distributing Warrant Holder, each person, if any, who controls (within the meaning of the Act) the Distributing Warrant Holder, and each officer, employee, partner or agent of the Distributing Warrant Holder, any other Distributing Warrant Holder or any such underwriter for use in the preparation thereof, and (ii) such losses, claims, damages or liabilities arise out of or are based upon any actual or alleged untrue statement or omission made in or from any preliminary prospectus, but corrected in the final prospectus, as amended or supplemented.

4

(b)

Whenever pursuant to Paragraph 5 a registration statement relating to the Common Stock issuable upon the exercise of this Warrant is filed under the Act, or is amended or supplemented, the Distributing Warrant Holder will indemnify and hold harmless the Company, each of its directors, each of its officers who have signed said registration statement or such amendments and supplements thereto, and each person, if any, who controls the Company (within the meaning of the Act) and each officer, employee, partner or agent of the Company against any losses, claims, damages or liabilities to which the Company or any such director, officer, controlling person, employee, partner or agent may become subject under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue or alleged untrue statement of any material fact contained in any such registration statement or any preliminary prospectus or final prospectus constituting a part thereof, or any amendment or supplement thereto, or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission was made in said registration statement, said preliminary prospectus, said final prospectus or said amendment or supplement in reliance upon and in conformity with written information furnished by such Distributing Warrant Holder for use in the preparation thereof; and will reimburse the Company or any such director, officer, controlling person, employee, partner or agent for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action.

(c)

Promptly after receipt by an indemnified party under this Paragraph 6 of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party, give the indemnifying party notice of the commencement thereof; but the omission to so notify the indemnifying party will not relieve it from any liability which it may have to any indemnified party otherwise than under this Paragraph 6.

(d)

In case any such action is brought against any indemnified party, and it notifies an indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate in, and, to the extent that it may wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof with counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party of its election to so assume the defense thereof, the indemnifying party will not be liable to such indemnified party under this Paragraph 6 for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation.

(e)

If an indemnifying party assumes the defense of a claim pursuant to Section 6(d), any settlement or compromise of such claim shall be effected only with the consent of the indemnified party, which consent shall not be unreasonably withheld.

 

5

7.

Adjustments of Purchase Price and Number of Shares.

(a)

Subdivision and Combination:  In case the Company shall at any time subdivide or combine the outstanding shares of Common Stock by way of stock split, reverse stock split or the like, the Exercise Price shall promptly be proportionately increased or decreased.

(b)

Adjustment in Number of  Shares:  Upon each adjustment of the Exercise Price pursuant to the provisions of this Section 7, the number of shares of Common Stock issuable upon the exercise of this Warrant shall be adjusted to a number of shares of Common Stock that is determined by multiplying a number equal to the Exercise Price in effect immediately prior to such adjustment by the number of  shares of Common Stock issuable upon exercise of this Warrant immediately prior to such adjustment and dividing the product so obtained by the adjusted Exercise Price.

(c)

Reclassification, Consolidation, Merger, etc.:  In case of any reclassification or change of the outstanding shares of Common Stock (other than a change in par value to no par value, or from no par value to par value, or as a result of a subdivision or combination), or in the case of any consolidation of the Company with, or merger of the Company into, another corporation (other than a consolidation or merger in which the Company is the surviving corporation and which does not result in any reclassification or change of the outstanding shares of Common Stock, except a change as a result of a subdivision or combination of such shares or a change in par value, as aforesaid), or in the case of a sale or conveyance to another corporation of all or a substantial part of the property of the Company, the Warrant Holder shall thereafter have the right to purchase the kind and number of shares of stock and other securities and property receivable upon such reclassification, change, consolidation, merger, sale or conveyance as if the Warrant Holder were the owner of the shares of Common Stock immediately prior to any such events at a price equal to the product of (x) the number of shares of Common Stock  issuable upon exercise of this Warrant and (y) the Exercise Price in effect immediately prior to the record date for such reclassification, change, consolidation, merger, sale or conveyance as if such Warrant Holder had exercised this Warrant.

(d)  

Dividends and Other Distributions with Respect to Outstanding Securities:  In the event that the Company shall at any time prior to the exercise of this Warrant declare a dividend (other than a dividend consisting solely of shares of Common Stock or a cash dividend or distribution payable out of current or retained earnings) or otherwise distribute to its shareholders any monies, assets, property, rights, evidences of indebtedness, securities (other than shares of Common Stock), whether issued by the Company or by another person or entity, or any other thing of value, the Warrant Holder of the unexercised Warrant shall thereafter be entitled, in addition to the shares of Common Stock or other securities receivable upon the exercise thereof, to receive, upon the exercise of this Warrant, the same monies, property, assets, rights, evidences of indebtedness, securities or any other thing of value that the Warrant Holder would have been entitled to receive at the time of such dividend or distribution if the Warrant Holder had exercised this Warrant immediately prior to such dividend or distribution. At the time of any such dividend or distribution, the Company shall make appropriate reserves to ensure the timely performance of the provisions of this Subsection 7(d).

 

6

(e)

Fractional Shares: Any fraction of a share which the Warrant Holder would be entitled to purchase upon exercise of this Warrant shall be rounded down to the nearest whole number of shares.  The Company will pay cash for the value of any fractional shares otherwise issuable. The Warrant Holder, by his acceptance hereof, expressly waives any right to receive any fractional share of stock upon exercise of this Warrant.

(f)

Warrant Certificate After Adjustment:  Irrespective of any change pursuant to this Section 7 in the Exercise Price or in the number, kind or class of shares or other securities or other property obtainable upon exercise of this Warrant, this Warrant may continue to express as the Exercise Price and as the number of shares of Common Stock obtainable upon exercise, the same price and number of shares of Common Stock as are stated herein.

(g)

Statement of Calculation: Whenever the Exercise Price shall be adjusted pursuant to the provisions of this Section 7, the Company shall forthwith file at its principal office, a statement signed by an executive officer of the Company specifying the adjusted Exercise Price determined as above provided in such section and a certificate of the independent public accountants regularly retained by the Company. Such statement shall show in reasonable detail the method of calculation of such adjustment and the facts requiring the adjustment and upon which the calculation is based. The Company shall forthwith cause a notice setting forth the adjusted Exercise Price to be sent by certified mail, return receipt requested, postage prepaid, to the Warrant Holder.

8.

Definition of "Common Stock."
 

For the purpose of this Warrant, the term "Common Stock" shall mean, in addition to the class of stock designated as the Common Stock of the Company on the date hereof, any class of stock resulting from successive changes or reclassifications of the Common Stock consisting solely of changes in par value, or from par value to no par value, or from no par value to par value. If at any time, as a result of an adjustment made pursuant to one or more of the provisions of Section 7 hereof, the shares of stock or other securities or property obtainable upon exercise of this Warrant shall include securities of the Company other than shares of Common Stock or securities of another corporation, then thereafter the amount of such other securities so obtainable shall be subject to adjustment from time to time in a manner and upon terms as nearly equivalent as practicable to the provisions with respect to Common Stock contained in Section 7 hereof and all other provisions of this Warrant with respect to Common Stock shall apply on like terms to any such other shares or other securities.

9.

Miscellaneous.

(a)

This Warrant shall be governed by and in accordance with the laws of the State of New York.

(b)

All notices, requests, consents and other communications hereunder shall be made in writing and shall be deemed to have been duly made when delivered, or mailed by registered or certified mail, return receipt requested: (i) if to a Warrant Holder, to the address of the Warrant Holder as shown on the books of the Company, or (ii) if to the Company, BioElectronics Corporation, 401 Rosemont Avenue, Third Floor, Rosenstock Hall, Frederick, Maryland 21701.

 

7

(c)

The Company and BB&R may from time to time supplement or amend this Warrant without the approval of the Warrant Holders in order to cure any ambiguity, to correct or supplement any provision contained herein which may be defective or inconsistent with any provisions herein, or to make any other provisions in regard to matters or questions arising hereunder which the Company and BB&R may deem necessary or desirable and which the Company and BB&R deem not to adversely affect the interest of the Warrant Holder, provided all such supplements, amendments and/or other provisions shall be in writing.

(d)

All the covenants and provisions of this Warrant by or for the benefit of the Company and the Warrant Holder inure to the benefit of their respective successors and assigns hereunder.

(e)

Nothing in this Warrant shall be construed to give to any person or corporation other than the Company and the Warrant Holder any legal or equitable right, and any such right is for the sole and exclusive benefit of the Company and the Warrant Holder.

[remainder of page intentionally left blank]

 

 

8

IN WITNESS WHEREOF, the Company has caused this  Warrant to be signed by its duly authorized officer as of this 4th day of April, 2005.

	 	BIOELECTRONICS CORPORATION
	 	 
	 	 
		
    	
    /s/ Andrew Whelan
			Name: Andrew Whelan
			Title:   President

9

PURCHASE FORM

(To be signed only upon exercise of the Warrant)

The undersigned registered owner of this Warrant irrevocably exercises this Warrant and agrees to purchase ____________shares of Common Stock of BioElectronics Corporation all at the price and on the terms and conditions specified in this Warrant.

Dated: __________________

_________________________

(Signature of Registered Owner)

_________________________

Address

______________________________

(City)   (State)    (Zip)

10

TRANSFER FORM

(To be signed only upon transfer of the Warrant)

 

For value received, the undersigned hereby sells, assigns, and transfers unto _____________________ the right to purchase Shares of Common Stock of BioElectronics Corporation represented by the foregoing Warrant to the extent of __________ Shares and appoints ________________, attorney to transfer such rights on the books of ________________, with full power of substitution in the premises.

	Dated: __________________
	 
	 
	 
	
    (name of Warrant Holder)
	 
	 
	 
	
    Address
	 
	 
	
    
	In the presence of:
	 
	 
	 
	 
	 
	 

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]